What should be administered to all intubated asthma patients with bronchospasm?

In-line nebulized Albuterol is administered to all intubated asthma patients with bronchospasm because it acts as a bronchodilator to relieve airway constriction. When patients are experiencing bronchospasm, particularly in the context of asthma exacerbations, it is crucial to quickly open the airways and facilitate airflow. Nebulized Albuterol helps achieve this effect by relaxing the smooth muscles in the airways, making it easier for the intubated patient to breathe.

Utilizing in-line nebulization allows for the medication to be delivered directly into the endotracheal tube during ventilation, which is essential for an intubated patient who cannot inhale the medication through traditional means. This method ensures that the medication remains effective and reaches the lungs quickly, which is vital in managing acute respiratory distress associated with severe asthma.

Oral corticosteroids, while effective in managing asthma inflammation, take time to work and are not appropriate for immediate relief of acute bronchospasm. Intravenous corticosteroids also serve to reduce inflammation but are not the first-line treatment for acute bronchospasm. Oxygen therapy, while necessary to ensure adequate oxygenation, does not directly address the underlying issue of bronchospasm and cannot relieve airway constriction on its own. Thus, in